Irving, Texas Clinical Trials

A listing of Irving, Texas clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 51 clinical trials
Tipifarnib for the Treatment of Advanced Solid Tumors Lymphoma or Histiocytic Disorders With HRAS Gene Alterations a Pediatric MATCH Treatment Trial

This phase II pediatric MATCH trial studies how well tipifarnib works in treating patients with solid tumors that have spread to other places in the body (advanced), lymphoma, or histiocytic disorders that have HRAS genetic alterations. Tipifarnib may block the growth of cancer cells that have specific genetic changes in …

hras gene
recurrent thyroid gland carcinoma
donor lymphocyte infusion
HRAS
nitrosoureas
UT Southwestern/Simmons Cancer Center-Dallas
 (6.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +82 other locations
Phase 2 Clinical Trial of Crizotinib for Children and Adults With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas

Subjects with Neurofibromatosis Type 2 (NF2) and progressive vestibular schwannoma (VS) will be treated with crizotinib administered orally. Crizotinib will be taken continuously until disease progression or unacceptable toxicity, in continuous treatment cycles of 28 days each, for a maximum of 12 cycles.

schwartz
glioma
neutrophil count
nf2 gene
crizotinib
Childrens Medical Center - Univ. of Texas SW (Site 917)
 (5.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +16 other locations
First-in-Human Study of XMT-1592 in Patients With Ovarian Cancer and NSCLC Likely to Express NaPi2b

Phase 1b, a study in high grade serous ovarian cancer and nonsmall cell lung cancer to evaluate the safety and clinical activity of the antibody-drug conjugate (ADC) XMT-1592.

primary peritoneal carcinoma
alopecia
hormonal contraception
non-small cell lung cancer
fallopian tube
Mary Crowley Cancer Research Center
 (8.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +2 other locations
THE ALIGN-AR PIVOTAL TRIAL: JenaValve Pericardial TAVR Aortic Regurgitation Study

To collect information about treatment for symptomatic severe Aortic Regurgitation (AR), which affects the aortic valve in the heart. Aortic regurgitation is a condition where aortic valve in the heart does not close tightly and allows some blood to leak back into the heart chamber. Symptoms of aortic regurgitation may …

regurgitation
shortness of breath
fatigue
aortic valve replacement
Baylor Scott & White Research Institute
 (8.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +9 other locations
A Study of CC-98633 BCMA-targeted Chimeric Antigen Receptor (CAR) T Cells in Subjects With Relapsed and/or Refractory Multiple Myeloma

This is a Phase 1, multicenter, open-label study of CC-98633, BCMA-Targeted NEX-T Chimeric Antigen Receptor (CAR) T Cells, in subjects with relapsed and/or refractory multiple myeloma. The study will consist of 2 parts: dose-escalation (Part A) and dose-expansion (Part B). The dose-escalation part (Part A) of the study is to …

proteasome inhibitor
immunotherapeutic agent
thalidomide
bcma
daratumumab
UT Southwestern Medical Center
 (6.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +8 other locations
Identification of Predictors for Clinical Outcomes in Femoroacetabular Impingement Surgery

The overarching goal of the study is to improve the surgical treatment outcomes of FAI, which is affecting an increasing number of military personnel and young active individuals in the general population. The proposed study will investigate critical patient, disease, and surgical treatment predictors of FAI surgery outcomes.

conservative management
hip arthroscopy
arthroscopy
femoroacetabular impingement
Texas Scottish Rite Hospital for Children
 (8.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +11 other locations
Pre-hospital Tourniquet in Extremity Injury

2.1. Objective: Primary Objective: To compare outcomes of patients with extremity injuries presenting with or without pre-hospital tourniquet placement. 2.2. Study Outcome Measures Primary Outcome: Incidence of arrival in shock (SBP <90) Secondary Outcomes: Demographics, comorbidities, mechanism of injury, cause of injury, diagnosis codes, procedure codes, ISS, AIS, operative management …

Methodist Dallas Medical Center
 (9.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Trauma Specific Frailty Index

Increasing age is a known predictor of morbidity and mortality after a traumatic injury with worst outcomes seen in patients with age greater than 65 years (9). Geriatric trauma patients are a unique cohort of patients who are highly prone to develop decompensated state following the stress of traumatic event …

Methodist Dallas Medical Center
 (9.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Optimal A1c Control in Post Liver or Combined Liver and Kidney Transplant Recipients Who Have Diabetes Mellitus

Major cardiovascular events are greatest in liver transplant recipients with sustained post-transplantation diabetes1. However, the optimal A1c target after transplantation has not been studied. The objective is to understand the optimal A1c target post liver and combined liver and kidney transplant. Strict A1c control will improve mortality and cardiovascular risk …

diabetes
liver transplant
hemoglobin a1c
diabetes mellitus
kidney transplant
Methodist Health System
 (9.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Pediatric KIDney Stone (PKIDS) Care Improvement Network

The goals of this study are to improve the ability of pediatric patients and their caregivers to select surgical treatment options for kidney stones and to enable urologists to use techniques that result in the best outcomes for these surgeries.

ureterolithiasis
pediatric
nephrolithotomy
nephrolithiasis
lithotripsy
Children's Medical Center of Dallas
 (5.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +21 other locations